General
Preferred name
CLOPIDOGREL BISULFATE
Synonyms
CLOPIDOGREL SULFATE ()
(S)-(+)-Clopidogrel bisulfate ()
SR-25990C ()
(S)-(+)-Clopidogrel hydrogen sulfate ()
(+)-Clopidogrel hydrogen sulfate ()
Clopidogrel bisulfate ()
Clopidogrel (hydrogen sulfate) ()
SR-25990C, Clopidogrel hydrogen sulfate, Iscover, Plavix ()
Clopidogrel (SR-25990C) Bisulfate ()
Clopidogrel hydrogen sulfate ()
(S)-(+)-Clopidogrel (sulfate) ()
Clopidogrel hydrogen sulphate ()
Clopidogrel sulfate ()
Clopidogrel ratiopharm ()
Clopidogrel bgr (previously zylagren) ()
Clopidogrel bisulphate ()
Clopidogrel (as hydrogen sulfate) ()
Clopidogrel teva (hydrogen sulphate) ()
Isocover ()
Clopidogrel bisulfate component of duoplavin ()
Clopidogrel bms ()
Clopidogrel zentiva ()
Clopidogrel teva ()
Zyllt ()
Clopidogrel bisulfate component of duocover ()
Clopidogrel bisulfate component of clopidogrel/acetylsalicyclic acid teva ()
Plavix ()
Clopidogrel (as bisulfate) ()
Clopidogrel-bgr ()
Pidogrel ()
Iscover ()
Clopidogrel zentiva (previously clopidogrel winthrop) ()
Clopidogrel-bms ()
SR 25990C ()
P&D ID
PD000885
CAS
113665-84-2
120202-66-6
144077-07-6
135046-48-9
Tags
available
prodrug
drug
Drug Status
approved
Max Phase
4.0
Drug indication
Acute coronary syndrome
First approval
1997
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
Clopidogrel hydrogen sulfate is an antiplatelet agent to prevent blood clots. Clopidogrel hydrogen sulfate inhibits CYP2B6 and CYP2C19 with IC50s of 18.2 nM and 524 nM, respectively[1]. Clopidogrel hydrogen sulfate is a potent antithrombotic agent that inhibits ADP-induced platelet aggregation[2]£®Clopidogrel hydrogen sulfate also is an orally active P2Y(12) inhibitor[5].
DESCRIPTION
Clopidogrel hydrogen sulfate is an antiplatelet agent which works by blocking platelets from sticking together and prevents them from forming harmful clots.
(Enamine Bioactive Compounds)
DESCRIPTION
Clopidogrel hydrogen sulfate ((S)-(+)-Clopidogrel bisulfate) , a selective, high-affinity P2Y12 receptor antagonist, suppressess fibrinogen binding to platelets and platelet adhesion and aggregation.
(TargetMol Bioactive Compound Library)
DESCRIPTION
Potent ETB antagonist
(Tocris Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
12
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Enamine Bioactive Compounds
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
27
Molecular Weight
419.03
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
2
cLogP
3.02
TPSA
104.14
Fraction CSP3
0.31
Chiral centers
1.0
Largest ring
6.0
QED
0.58
Structural alerts
2
aggregator (Aggregator Advisor)
Aggregators
aggregator (ZINC)
Aggregators
Related compounds
Custom attributes
(extracted from source data)
Target
Cytochrome P450
P2Y
P2Y Receptor
P2 Receptor
Primary Target
Purinergic (P2Y) Receptors
MOA
Antagonist
Pathway
GPCR/G protein
Metabolic Enzyme/Protease
Metabolism
Neuroscience
Source data
